Stocks are moving broadly higher on Wall Street in morning trading Monday as investors welcome news of several big corporate deals.
The S&P 500 was up 1.6%, led by gains technology, health care and communication stocks. The gains reversed more than half of the benchmark index's losses from last week, when the S&P 500 posted its biggest weekly decline since June. Treasury yields were mixed.
Nvidia jumped 6.4%, one of the biggest gainers in the S&P 500, after announcing plans to buy fellow chipmaker Arm Holdings in a deal worth up to $40 billion. Oracle climbed 4.9% after the business software maker beat out Microsoft to become the “trusted technology provider” of TikTok, the popular video-sharing app based in China. And the stock of Immunomedics more than doubled after the cancer drug specialist agreed to be acquired by Gilead Sciences in a $21 billion deal. Gilead shares rose 3.4%.
AstraZeneca was up 1% following news over the weekend that clinical trials for the pharmaceutical company's coronavirus vaccine will resume after being paused due to a reported side-effect in a patient in the U.K. The vaccine is seen as one of the strongest contenders among the dozens of coronavirus vaccines being tested.
The Dow Jones Industrial Average was up 328 points, or 1.2%, to 27,993 as of 11:24 a.m. Eastern time. The Nasdaq, which includes many tech stocks, rose 2.3%. European markets were mixed and Asian markets closed broadly higher.
The S&P 500 is coming off a two-week slide amid increased volatility in the market as investors turn cautious following a five-month rally for stocks fueled largely by a run-up in big tech companies.
The pandemic accelerated the use of online services by businesses and individuals, driving shares of Apple, Amazon, Microsoft, Zoom Video and other tech companies sharply higher through the summer. But concerns that the high-flying tech stocks had soared too high have put investors in a selling mood in September. The S&P 500 is down 3% so far this month, while the Nasdaq has pulled back 5.8%.
One big factor that remains in the stock market’s favor is the Federal Reserve, which continues to pump aid into the economy. It has slashed short-term interest rates to record lows and bought up all kinds of bonds to support markets. It also said recently it will keep delivering stimulus even if inflation rises above its target level, as long as inflation had been well under it before then.
Investors will be focused this week on the central bank's latest interest rate and economic policy update on Wednesday.
The yield on the 10-year Treasury held steady at 0.67%.
European markets were mixed, while Asian markets closed broadly higher.
___
Yuri Kageyama is on Twitter https://twitter.com/yurikageyama
Before you consider Microsoft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microsoft wasn't on the list.
While Microsoft currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
